Alloy vs LifeForce

Vial Take

Both are telehealth platforms with clean federal records and board-certified physician oversight, so neither raises red flags on the regulatory side. LifeForce edges ahead on trust score (81 vs 75) and wins clearly on pharmacy transparency: Empower Pharmacy is named, which lets you verify the compounding supply chain before you commit, while Alloy leaves that piece undisclosed. Where Alloy pulls ahead is clinical specificity: its physicians carry verifiable menopause specialization credentials, versus LifeForce's more generic "board-certified nationwide" description, so if women's hormone health is your focus, Alloy's clinicians are a stronger match even if its supply chain needs a follow-up question.

Biggest Differences

1. 1
   Pharmacy disclosure
   LifeForce publishes its compounding partner (Empower Pharmacy), so you can verify the supply chain; Alloy does not name a pharmacy partner publicly.
2. 2
   Geographic reach
   LifeForce is available in all 50 states compared to Alloy's 0, which may decide the question before any other signal if you're outside Alloy's footprint.
3. 3
   Trust Score gap (6 points)
   LifeForce scores 81/100 to Alloy's 75/100, a 6-point spread driven by the differences below.